Human Vaccines & Immunotherapeutics

Papers
(The H4-Index of Human Vaccines & Immunotherapeutics is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Single-cell analysis unravels the role of NK cells and monocytes in the control of SARS-CoV-2 breakthrough infections in vaccinated individuals339
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies298
Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study176
A novel anti-PcrV monoclonal antibody inhibits toxin-mediated cytotoxicity and enhances survival in mouse models of Pseudomonas aeruginosa infection162
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary111
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children81
Enhancing COVID-19 booster vaccination among the elderly through text message reminders77
Acceptability of patient-centered digital vaccine safety monitoring: A Canadian Immunization Research Network study76
Factors associated with willingness to accept pneumococcal vaccine based on the Health Belief Model among the elderly (≥60 years) living in Klang Valley, Malaysia76
Medical students’ knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer68
Acute encephalitis after COVID-19 vaccination: A case report and literature review68
The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic67
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality63
Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic revi62
Determinants of basic childhood vaccination coverage in European and OECD countries62
Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges61
Associations between vaccination clinic factors and DTaP dropout in China: A cross-sectional study59
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children59
Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States58
Correction58
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling55
Plasma therapy: a passive resistance against the deadliest54
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China53
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 202153
Human vaccines & immunotherapeutics: News October 202253
Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’50
Vaccine manufacturing is essential to ensure access50
Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China47
Human vaccines & immunotherapeutics: news October 202147
Improving Tdap maternal immunization rate in Saudi Arabia46
HV&I Reviewer Highlight46
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons45
A cross-sectional study assessing Pro-VC-Be short-form questionnaire in Canada; measuring psychosocial determinants of vaccination behavior in Canadian healthcare professionals45
Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study44
Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia41
Human vaccines and immunotherapeutics: News December 202341
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control41
Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children39
Immune response to and virological profile of SARS-CoV-2 before and after symptom onset in individuals vaccinated with inactivated COVID-19 vaccines39
0.14431500434875